Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2020C523 Product name: Relebactam, desgewenst in de vorm van het monohydraat, en imipenem

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2020C/523
Type:
Certificate
SPC type:
Medical
Basic patent number:
131809691
Status:
Open & Published
Publication number:
2020C523
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EU/1/19/1420
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
17/02/2020
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
01/07/2020
First marketing authorization date:
17/02/2020
Grant date:
Activation date:
BE Publication date:
02/07/2020
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
15/01/2034
SPC/SPC Extension Expiration (if granted and all annual fees paid):
15/01/2034
Rejection date:
Withdrawal date:

Applicant

1

Name:
Merck Sharp & Dohme LLC
Legal Form:
From:
18/10/2022
Address:
126 East Lincoln Avenue, P.O. Box 2000, Rahway, New Jersey 07065, United States (US)
To:

2

Name:
Merck Sharp & Dohme Corp.
Legal Form:
Corp.
From:
02/07/2020
Address:
126 East Lincoln Avenue, 07065-0907, Rahway, United States (US)
To:
18/10/2022

Agent

1

Name:
NLO
Legal Form:
From:
27/11/2024
Address:
New Babylon City Offices Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)
To:

2

Name:
NLO
Legal Form:
From:
02/07/2020
Address:
Technologiepark 122, 9052, ZWIJNAARDE - GENT, Belgium (BE)
To:
27/11/2024

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2020/18
Publication date:
21/08/2020
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
CO
Journal edition number:
2022/23
Publication date:
04/01/2023
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders

Deed

Change of owner(s)

Change Kind / Decision Type:
Merge
Deed number:
RC2022100978A
Registration date:
18/10/2022
License effective date:
License expiration date:
Scope of license:
Deed filer:
POLVERARI Luca
Bulletin edition number:
Text:
Country code:
Updated license number:
Terminated license number:

Removed pledgee

Name:
Address:

Changed pledgee

Name:
Address:

Removed usufructuary

Name:
Address:

Added usufructuary

Name:
Address:

Changed usufructuary

Name:
Address:

Annual fee

Annual fee(s) Due Date:
31/01/2029
Annual fee number:
21
Annual fee amount:
650 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
01/07/2020 MA Official Publication Official Publication of 1st Marketing Authorization 10 PDF /5/3/5/4/1/0722014535/docs/2020c523_0_maofficialpublication_20200702_084734668.pdf
02/07/2020 Publication I1 1 PDF /5/3/5/4/1/0722014535/docs/2020c523_1_i1document_20200702_105302739.pdf
02/07/2020 Outgoing Correspondence 2 PDF /5/3/5/4/1/0722014535/docs/2020c523_2_outgoingcorrespondence_20200703_023000602.pdf
01/07/2020 Abstract Product Characteristics Abstract of the characteristics of the product 19 PDF /5/3/5/4/1/0722014535/docs/2020c523_3_abstractproductcharacteristics_20200702_084735045.pdf
18/10/2022 Request For Change Free translation of the deed or extract 5 PDF /5/3/5/4/1/0722014535/docs/2020c523_4_rfc_20221019_084528822.pdf
18/10/2022 Request For Change Deed or extract stating the change of the rights 5 PDF /5/3/5/4/1/0722014535/docs/2020c523_5_rfc_20221019_084529151.pdf
18/10/2022 Request For Change Power of attorney deed 7 PDF /5/3/5/4/1/0722014535/docs/2020c523_6_rfc_20221019_084529401.pdf
18/10/2022 Request For Change Letter and/or Form requesting a change in the Register 3 PDF /5/3/5/4/1/0722014535/docs/2020c523_7_rfc_20221019_084529616.pdf
18/10/2022 Incoming Correspondence (Email) Cover letter 1 PDF /5/3/5/4/1/0722014535/docs/2020c523_8_incomingcorrespondenceelectronic_20221019_084529735.pdf
18/10/2022 Outgoing Correspondence 1 PDF /5/3/5/4/1/0722014535/docs/2020c523_9_outgoingcorrespondence_20221019_084528693.pdf
01/07/2020 Application Form 4 PDF /5/3/5/4/1/0722014535/docs/2020c523_10_applicationform_20200702_084740059.pdf
01/07/2020 Marketing Authorization 1st Marketing Authorization (EU) 3 PDF /5/3/5/4/1/0722014535/docs/2020c523_11_marketingauthorization_20200702_084739550.pdf
27/11/2024 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /5/3/5/4/1/0722014535/docs/2020c523_12_rfc_20241127_012947133.pdf
27/11/2024 Outgoing Correspondence Outgoing Correspondence 2 PDF /5/3/5/4/1/0722014535/docs/2020c523_13_206455_pie.rfc.per.notif.pdf